Medpace Holdings Revenue 2014-2025 | MEDP

Medpace Holdings annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Medpace Holdings revenue for the quarter ending March 31, 2025 was $0.559B, a 9.3% increase year-over-year.
  • Medpace Holdings revenue for the twelve months ending March 31, 2025 was $2.157B, a 9.87% increase year-over-year.
  • Medpace Holdings annual revenue for 2024 was $2.109B, a 11.84% increase from 2023.
  • Medpace Holdings annual revenue for 2023 was $1.886B, a 29.17% increase from 2022.
  • Medpace Holdings annual revenue for 2022 was $1.46B, a 27.8% increase from 2021.
Medpace Holdings Annual Revenue
(Millions of US $)
2024 $2,109
2023 $1,886
2022 $1,460
2021 $1,142
2020 $926
2019 $861
2018 $705
2017 $436
2016 $422
2015 $359
2014 $326
2013 $273
Medpace Holdings Quarterly Revenue
(Millions of US $)
2025-03-31 $559
2024-12-31 $537
2024-09-30 $533
2024-06-30 $528
2024-03-31 $511
2023-12-31 $498
2023-09-30 $492
2023-06-30 $461
2023-03-31 $434
2022-12-31 $394
2022-09-30 $384
2022-06-30 $351
2022-03-31 $331
2021-12-31 $309
2021-09-30 $296
2021-06-30 $278
2021-03-31 $260
2020-12-31 $260
2020-09-30 $230
2020-06-30 $205
2020-03-31 $231
2019-12-31 $230
2019-09-30 $216
2019-06-30 $214
2019-03-31 $201
2018-12-31 $192
2018-09-30 $179
2018-06-30 $170
2018-03-31 $163
2017-12-31 $113
2017-09-30 $111
2017-06-30 $106
2017-03-31 $107
2016-12-31 $108
2016-09-30 $108
2016-06-30 $106
2016-03-31 $100
2015-12-31
2015-09-30 $92
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $8.785B $2.109B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.350B 26.32
Elevance Health (ELV) United States $91.117B 11.76
CVS Health (CVS) United States $79.102B 9.83
Cencora (COR) United States $56.251B 19.57
DiDi Global (DIDIY) China $21.979B 33.36
Natera (NTRA) United States $20.836B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.822B 13.57
EUROFINS SCIENT (ERFSF) Luxembourg $12.604B 0.00
CochLear (CHEOY) Australia $11.282B 0.00
Revvity (RVTY) United States $10.993B 18.92
ICON (ICLR) Ireland $10.630B 9.88
Viatris (VTRS) United States $10.375B 3.56
Doximity (DOCS) United States $9.813B 45.70
Avantor (AVTR) United States $9.138B 13.28
HealthEquity (HQY) United States $8.497B 41.80
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.924B 13.57
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.257B 39.40
Bausch + Lomb (BLCO) Canada $4.156B 24.50
Sotera Health (SHC) United States $3.633B 20.65
Alignment Healthcare (ALHC) United States $3.122B 0.00
Surgery Partners (SGRY) United States $3.068B 39.90
Concentras Parent (CON) United States $2.912B 16.83
Organon (OGN) United States $2.350B 2.50
Ardent Health Partners (ARDT) United States $2.204B 9.40
GeneDx Holdings (WGS) United States $1.949B 75.07
Progyny (PGNY) United States $1.912B 42.08
Premier (PINC) United States $1.904B 14.45
PACS (PACS) United States $1.647B 0.00
GoodRx Holdings (GDRX) United States $1.414B 28.29
Teladoc Health (TDOC) United States $1.319B 0.00
Pediatrix Medical (MD) United States $1.283B 9.76
Establishment Labs Holdings (ESTA) $1.046B 0.00
Agilon Health (AGL) United States $1.014B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.977B 15.25
Nutex Health (NUTX) United States $0.972B 14.69
AMN Healthcare Services Inc (AMN) United States $0.869B 8.13
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.702B 4.73
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.33
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.487B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.370B 0.00
SBC Medicals (SBC) United States $0.352B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.218B 0.00
Performant Healthcare (PHLT) United States $0.209B 0.00
DocGo (DCGO) United States $0.150B 24.50
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
KindlyMD (KDLY) United States $0.078B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00